(Q43940289)

28 November 2017

title

Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia (English)

1 reference

bronchopulmonary dysplasia

28 November 2017

main subject

1 reference

Peter M Mourani

1

1 reference

28 November 2017

D Dunbar Ivy

series ordinal

2

1 reference

28 November 2017

Dexiang Gao

series ordinal

3

1 reference

28 November 2017

Steven H Abman

series ordinal

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

7 June 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

170

1 reference

28 November 2017

issue

9

1 reference

28 November 2017

page(s)

1006-1013

1 reference

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pulmonary function in infancy and in childhood following mechanical ventilation in the neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Long-term pulmonary functional outcome of bronchopulmonary dysplasia and premature birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pulmonary vascular changes in bronchopulmonary dysplasia: a clinicopathologic correlation in short- and long-term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Changes in pulmonary circulation in severe bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pathology of new bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Long-term follow-up of bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Monitoring cardiovascular function in infants with chronic lung disease of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Primary pulmonary hypertension: Current therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high-altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

10.1164/RCCM.200310-1483OC

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference